BRIEF-Boehringer Ingelheim's HY Net Sales Reach EUR 15.8 Billion

July 15 (Reuters) - Boehringer Ingelheim:

  • BOEHRINGER INGELHEIM REPORTS FIRST-HALF 2026 SALES GROWTH, DRIVEN BY JARDIANCE® AND NEW PRODUCT LAUNCHES IN THE U.S.

  • BOEHRINGER INGELHEIM: HY NET SALES REACH EUR 15.8 BILLION

  • BOEHRINGER INGELHEIM: EXPECTS RECENT LAUNCHES, UPCOMING PIPELINE MILESTONES, ONGOING INVESTMENTS TO SUPPORT PERFORMANCE FOR REMAINDER OF YEAR

Source text: ID:nGNX4J1T8T


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.